Robert J Deluccia is Director of Acurx Pharmaceuticals, Inc.. Currently has a direct ownership of 960,935 shares of ACXP, which is worth approximately $1.3 Million. The most recent transaction as insider was on Jan 03, 2024, when has been sold 19,737 shares (Common Stock) at a price of $3.55 per share, resulting in proceeds of $70,066. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 961K
0% 3M change
8.59% 12M change
Total Value Held $1.3 Million

ROBERT J DELUCCIA Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 03 2024
BUY
Exercise of conversion of derivative security
$70,066 $3.55 p/Share
19,737 Added 2.01%
960,935 Common Stock
Dec 22 2023
SELL
Bona fide gift
-
30,000 Reduced 3.09%
941,198 Common Stock
Dec 12 2023
SELL
Bona fide gift
-
40,000 Reduced 3.96%
971,198 Common Stock
Jul 27 2022
BUY
Open market or private purchase
$75,001 $3.8 p/Share
19,737 Added 1.84%
1,051,198 Common Stock
Dec 02 2021
SELL
Bona fide gift
-
40,000 Reduced 3.81%
1,011,198 Common Stock
Nov 19 2021
BUY
Open market or private purchase
$24,667 $4.9 p/Share
5,034 Added 0.49%
1,031,461 Common Stock
RJD

Robert J Deluccia

Director
Staten Island, NY

Track Institutional and Insider Activities on ACXP

Follow Acurx Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACXP shares.

Notify only if

Insider Trading

Get notified when an Acurx Pharmaceuticals, Inc. insider buys or sells ACXP shares.

Notify only if

News

Receive news related to Acurx Pharmaceuticals, Inc.

Track Activities on ACXP